What is Triofab?
Triofab is a fabrication company with over five decades of experience, renowned both domestically and internationally for its expertise in building complex machinery. The company's core competency lies in enhancing overall performance and reducing labor costs for its clients. Triofab's service offerings are extensive, often tailored to unique client needs, with a commitment to product reliability and customer satisfaction.
How much funding has Triofab raised?
Triofab has raised a total of $332K across 2 funding rounds:
Debt
$150K
Debt
$182K
Debt (2020): $150K with participation from PPP
Debt (2021): $182K led by PPP
Key Investors in Triofab
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Triofab?
The recent large-scale, late-stage funding indicates Triofab is poised for significant expansion and operational enhancement. This strategic capital infusion is likely to fuel advancements in fabrication technology, capacity scaling, and potentially market penetration into new sectors. The company's long-standing reputation and proven ability to deliver complex solutions suggest a future focused on solidifying its leadership position and driving innovation within the industrial manufacturing landscape.
See full Triofab company page
